Generic Name: ibrutinib

Pill with imprint ibr 280 is Purple, Oval and has been identified as Imbruvica 280 mg. It is supplied by Pharmacyclics, Inc.

Imbruvica is used in the treatment of Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma; Waldenström Macroglobulinemia; Lymphoma; Mantle Cell Lymphoma and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 280 mg is not a controlled substance under the Controlled Substances Act (CSA).